<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02720705</url>
  </required_header>
  <id_info>
    <org_study_id>AssuitU</org_study_id>
    <nct_id>NCT02720705</nct_id>
  </id_info>
  <brief_title>Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children</brief_title>
  <official_title>Transbucal Dexmedetomidine for the Prevention of Emergence Agitation After Sevoflurane Anaesthesia in Pre-school Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the efficacy of transbucal dexmedetomidine given in
      preschool children undergoing tonsillectomy operations in the prevention sevoflurane
      agitation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Agitation during the emergence from general anesthesia is a great post-operative problem that
      often injures the patients themselves and requires the medical staff to restrain and calm
      them. The predisposing factors for emergence agitation include anesthesia, operation, and
      patient. Sevoflurane anesthesia results in higher incidence of emergence agitation than
      halothane, because of the rapid emergence, and its effects on central nervous system inducing
      convulsion and post-operative behavioral changes. The otorhinolaryngologic and ophthalmologic
      surgeries, post-operative pain, young age, pre-operative anxiety, no past surgical history,
      and adjustment disorder of patients are risk factors.

      Dexmedetomidine (DEX), a selective α (2)-adrenoreceptor agonist. Intravenous DEX used after
      induction of anesthesia reduced sevoflurane-associated EA and postoperative pain in pediatric
      ambulatory surgery.

      The investigators designed this study to prove the efficacy of oral dexmedetomidine a
      selective α (2)-adrenoreceptor agonist, on emergence agitation (EA), recovery profiles, and
      parents' satisfaction after sevoflurane anesthesia in tonsillectomy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The agitation score up to 1hour postoperative.</measure>
    <time_frame>first postoperative hour</time_frame>
    <description>Agitation intensity will be assessed postoperatively by using agitation score 0= child is asleep. awake/calm =1. irritable/ consolable cry =2. inconsolable cry =3.the child is agitating and thrashing and restlessness Emergence delirium ≥ 3 agitation score will be performed in the following time points; at 5 min postoperative,10 min, 15, 30, 45, 60 min.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score assessed using the objective pain scale.</measure>
    <time_frame>up to 1hour postoperative hour</time_frame>
    <description>Pain intensity will be assessed postoperatively by using the objective pain scale. objective pain scale assessments will be performed in the following time points; at 5 min postoperative, 10 min, 15, 30, 45, 60 min.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Agitation</condition>
  <arm_group>
    <arm_group_label>DEX I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>active comparator receive 1µg/kg dexmedetomidine orally half an hour before operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2ml oral 0.9%saline half an hour before operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DEX II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>active comparator receive,2µg/kg dexmedetomidine orally half an hour before operation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>oral dexmedetomidine</description>
    <arm_group_label>DEX I</arm_group_label>
    <arm_group_label>DEX II</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>2ml 0.9% saline administered orally half an hour before induction of anesthesia</description>
    <arm_group_label>Saline Control</arm_group_label>
    <other_name>0.9% saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical status I-II patients

          -  aged 2-6 years

          -  patient scheduled for elective tonsillectomy due to recurrent

          -  chronic tonsillitis

        Exclusion Criteria:

          -  patients with known hypersensitivity to medication drugs

          -  coagulation disorders

          -  thrombocytopenia

          -  significant cardiac

          -  renal

          -  z pulmonary

          -  hepatic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Halla s Abdel-Ghaffar Abdel-Ghaffar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>assisstant professor in anesthesia and intensive care departement,faculty of medicine,Assiut university,Egypt</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Halla Abdel-Ghaffar, MD</last_name>
    <phone>+20101003812011</phone>
    <email>hallasaad@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amani Abdel-wahab, MD</last_name>
    <phone>+201004610623</phone>
    <email>amanihassan1976@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assiut university hospitals</name>
      <address>
        <city>Assiut</city>
        <zip>Assiut,Egypt,71571</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hala S Abdel-Ghaffar, MD</last_name>
      <phone>+01003812011</phone>
      <email>hallasaad@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Amani Hassan abdel-wahab, MD</last_name>
      <phone>+01004610623</phone>
      <email>amanihassan1976@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2016</study_first_submitted>
  <study_first_submitted_qc>March 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2016</study_first_posted>
  <last_update_submitted>December 25, 2017</last_update_submitted>
  <last_update_submitted_qc>December 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Hala Saad Abdel-Ghaffar</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>sevoflurane emergence agitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

